Γ

SynBioBeta Speaker

Babu Raman

Corteva Agriscience

External Collab. Portfolio Leader

Babu Raman is an External Collaborations Portfolio Leader in Crop Protection Research & Development at Corteva Agriscience, based in Indianapolis, Indiana. In this role, he leads strategic external partnerships in biologicals and natural products, supporting innovation across Crop Health R&D and working at the interface of internal research teams and external technology providers. His responsibilities include shaping collaboration portfolios, aligning external innovation with internal R&D priorities, and supporting decision making across research, development, and technology scouting initiatives. He works closely with cross functional stakeholders to advance collaborative programs that strengthen Corteva’s crop protection and biologicals pipeline. Babu holds a Ph.D. in Biochemical Engineering from the University of Maryland and a B.Tech. in Chemical Engineering from the Indian Institute of Technology, Madras. He joined Dow AgroSciences (now Corteva) in 2011 following a postdoctoral fellowship at Oak Ridge National Laboratory. With a professional background spanning systems and synthetic biology, natural product discovery, strain and bioprocess development and external innovation, he focuses on aligning emerging technologies with Corteva’s research and development priorities.

SynBioBeta 2026 Tickets are Live

Confirmed Speakers

Sessions Featuring

Babu

This Year

Breakout Session

3:30 PM

-

4:15 PM

Biomanufacturing

Full Stack Bio: How Can Biotech Collaborate to Achieve Scale with Competitive COGS

Scaling bio-based products requires integrated technical collaboration across strain engineering, fermentation, downstream processing, and analytics. Full-stack approaches—where startups, CDMOs, and platform technology providers align early on—can optimize yield, reduce variability, and lower cost of goods (COGS) at commercial scale. This session explores case studies of cross-company collaboration, from co-development of microbial strains and bioreactor designs to shared process analytics and predictive modeling. Hear how teams are breaking down technical silos to accelerate scale-up, improve reproducibility, and create competitive, sustainable manufacturing solutions that bring synthetic biology products from the lab to the market efficiently.

Get a Ticket

Breakout Session

3:30 PM

-

4:15 PM

Biomanufacturing

Full Stack Bio: How Can Biotech Collaborate to Achieve Scale with Competitive COGS

Scaling bio-based products requires integrated technical collaboration across strain engineering, fermentation, downstream processing, and analytics. Full-stack approaches—where startups, CDMOs, and platform technology providers align early on—can optimize yield, reduce variability, and lower cost of goods (COGS) at commercial scale. This session explores case studies of cross-company collaboration, from co-development of microbial strains and bioreactor designs to shared process analytics and predictive modeling. Hear how teams are breaking down technical silos to accelerate scale-up, improve reproducibility, and create competitive, sustainable manufacturing solutions that bring synthetic biology products from the lab to the market efficiently.

Get a Ticket

TBD

Session lineup still growing

Get a Ticket

Featuring

Speaker Coming Soon

Fireside Chat

12:00 AM

-

8:30 AM

Human Health

From Cells to Patients: Solving the Scale Mismatch in Virtual Biology

Drug discovery often measures biology at the cell level while interventions work at the tissue, organ, or whole-patient scale. This mismatch can make accurate cell-level predictions irrelevant in the clinic. This session dives into strategies to bridge that gap: multiscale modeling that nests single-cell dynamics within organ-level simulations, spatial transcriptomics that preserve context, and surrogate models that translate cell-level outputs into clinical biomarkers. Speakers will ask: how do we ensure virtual biology reflects not just what cells do in isolation, but how biology behaves in the real complexity of patients?

Get a Ticket

Featuring

Speaker Coming Soon

Previous Speakers Include